Loading patent…
AssigneeChia Tai Tianqing Pharmaceutical Group Co., Ltd.
InventorsShanchun WANG, Ding YU, Xunqiang WANG, Bangan PENG, Lu LIU, Jie DAI, Hang ZHOU, Yadong MIAO
Estimating the term…
The present application relates to the field of medicine, and provided thereby is a quinoline derivative used for treating small cell lung cancer. The 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropylamine or a pharmaceutically acceptable salt thereof as provided by the present application may be used for the treatment of small cell lung cancer, especially for patients suffering from refractory relapsed small cell lung cancer, which may significantly prolong the survival time thereof; in addition, the therapeutic effect on brain metastatic small cell lung cancer is also very significant.
1-8. (canceled)
A method for treating small cell lung cancer, comprising administering to a patient in need of treatment a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof,
(canceled)
A method for treating small cell lung cancer, comprising administering to a patient in need of treatment a therapeutically effective amount of a pharmaceutical composition wherein the pharmaceutical composition comprises a compound of formula I or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier,
Dependencies are inferred from the claim text.